Detalhe da pesquisa
1.
Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia.
Brain
; 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527854
2.
CSF proteomic signature predicts progression to Alzheimer's disease dementia.
Alzheimers Dement (N Y)
; 8(1): e12240, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35229020
3.
Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
Alzheimers Res Ther
; 10(1): 58, 2018 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29933741
4.
Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders.
Alzheimers Dement (Amst)
; 7: 99-106, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28337476
5.
Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?
Alzheimers Dement (Amst)
; 1(1): 75-80, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27239494